Navigation Links
Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
Date:5/27/2009

Fertility and Sterility Publishes Article Underscoring Importance of PGD Technique and Method

LIVINGSTON, N.J., May 27 /PRNewswire/ -- A group of fertility experts, who pioneered the development of Preimplantation Genetic Screening (PGS), are sharing the step-by-step best practices and explaining what errors can be made along the way.

The article, published in the latest edition of Fertility and Sterility, details when PGS should be used, emphasizes proper embryo biopsy technique and reveals the most common errors made with the ultimate goal of educating clinics, embryologists and other experts to improve pregnancy outcomes.

When done correctly, PGS can be used to improve the success of in vitro fertilization (IVF) for women of advanced maternal age and recurrent pregnancy loss. Research shows that many times IVF fails because a majority of embryos created in vitro are chromosomally abnormal. When done correctly, PGS screens the most important chromosomes in terms of preimplantation aneuploidy (22, 16, 21 and 15), improving implantation rates.

Dr. Santiago Munne, of Reprogenetics, LLC. in Livingston, NJ, who has performed close to 15 thousand PGS cases, says this article is a must-read in any center that performs PGS.

"This article is the result of years of research and refining the PGS technique that have allowed us to achieve the success rates that we have seen," says Dr. Munne. "The techniques and technology described in this paper are required in order to improve successful pregnancy outcomes."

The article gives explicit detail about each step of the PGS process including opening the zona pellucida, removing the cell, cell fixation, how many chromosomes should be analyzed, and error rate criteria. As previous studies have shown, improper technique as well as inexperienced technicians or inadequate training, can lead to extremely increased error rates and ultimately IVF failure.

"The problem is, entire studies have been conducted where proper protocol has not been followed, causing doctors to come to conclusions that are often inaccurate," states Munne. "It is clear that not all laboratories can reproduce positive results. In those laboratories, PGS should be considered experimental."

To find a clinic that meets the protocol as published in Fertility and Sterility, requirements for preimplantation genetic diagnosis, contact client services at Reprogenetics, LLC - clientservices@reprogenetics.com or 973-436-5004.

    Contact:    Deborah Sittig
                Green Room PR
                Office: 973-263-8585 ext. 22
                Cell: 908-377-8700
                Deborah@greenroompr.com


'/>"/>
SOURCE Reprogenetics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
2. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
3. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
4. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
5. Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
8. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
9. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
10. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
11. Newly Approved HIV Drug Shows Great Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):